Phakic IOL outcomes remain favorable as trials continue

Phase III studies for high myopia, hyperopia show stable refractions, few complications

Related Content:

Pharmacy

Comparable conscious sedation methods address individual patient needs

Investigators uncover health care disparities among US patients

Investigators zoom in on future of dry eye treatment